Big Pharma’s China gamble

US House Speaker Mike Johnson sent home Congress members early to avoid a vote on releasing files on Jeffery Epstein, Nigeria’s recalculated GDP reflects a 30 per cent growth of its economy, and US President Donald Trump’s tariffs have hit General Motors' profits. Plus, global pharma companies have spent a record amount on Chinese biotech this year and Coca-Cola is putting cane sugar back in Coke.

Mentioned in this podcast:

Mike Johnson shuts US House early to avoid Epstein vote

Nigeria’s economy 30% bigger after GDP recalculation

 Big Pharma is increasingly reliant on Chinese biotech advances

GM profits hit by Trump’s tariffs while EV sales more than double

Coca-Cola to launch cane sugar-based Coke in US this autumn

Today’s FT News Briefing was produced by Sonja Hutson, Katya Kumkova, and Marc Filippino. Additional help from Kelly Garry and Michael Lello. Our acting co-head of audio is Topher Forhecz. Our intern is Michaela Seah. The show’s theme song is by Metaphor Music.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.